Pathogenicity and virulence of Hepatitis B virus
Related Experiment Video
Updated: Oct 5, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Yu-Chen Chuang1, Kuen-Nan Tsai1, Jing-Hsiung James Ou1
1Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, CA 90089, USA.
Insights
Hepatitis B virus (HBV) infects 296 million globally, causing severe liver disease. This review details HBV replication, host interactions, and factors driving pathogenesis and cancer.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis B virus (HBV) is a major global health concern, with 296 million chronically infected individuals.
- Chronic HBV infection can lead to severe liver conditions such as hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).
Purpose of the Study:
- To review the molecular mechanisms governing HBV replication.
- To explore HBV's interactions with host cells.
- To discuss factors contributing to HBV pathogenesis and carcinogenesis, including host immune responses.
Main Methods:
- This is a review article, synthesizing existing research.
- Literature search and analysis of molecular pathways.
- Examination of viral and non-viral factors in HBV pathogenesis.
Main Results:
- HBV replication involves a unique reverse transcription pathway.
- Complex interactions occur between HBV and host cellular machinery.
- Viral, non-viral, and host immune factors significantly influence disease progression.
Conclusions:
- Understanding HBV molecular pathways is crucial for disease management.
- Host immune responses play a dual role in viral persistence and liver damage.
- Further research into HBV pathogenesis and carcinogenesis is warranted.
Abstract:
Hepatitis B virus (HBV) is a hepatotropic virus and an important human pathogen. There are an estimated 296 million people in the world that are chronically infected by this virus, and many of them will develop severe liver diseases including hepatitis, cirrhosis and hepatocellular carcinoma (HCC). HBV is a small DNA virus that replicates via the reverse transcription pathway. In this review, we summarize the molecular pathways that govern the replication of HBV and its interactions with host cells. We also discuss viral and non-viral factors that are associated with HBV-induced carcinogenesis and pathogenesis, as well as the role of host immune responses in HBV persistence and liver pathogenesis.
Related Concept Videos
Subviral Agents
Viruses with RNA Genomes
Introduction to Virus
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Retroviruses
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

